We are pretty much through the 'dog days' of summerThe last month has been a relatively uneventful one for the biotech sectorThe iShares Nasdaq Biotechnology ETF (IBB) is trading close to exactly where it was one month agoTrading volume continues to be extremely tepid as a good portion of Wall Street is on extended summer retreats which should end...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.